Long-term effectiveness of ranibizumab for age-related macular degeneration and diabetic macular edema
Angie HC Fong,1 Timothy YY Lai1,2 1Department of Ophthalmology and Visual Sciences, The Chinese University of Hong Kong, Hong Kong Eye Hospital, Kowloon, Hong Kong; 22010 Retina and Macula Centre, Tsimshatsui, Kowloon, Hong Kong Abstract: Neovascular age-related macular degeneration (AMD) and diabe...
Saved in:
Main Authors: | Fong AH, Lai TY |
---|---|
Format: | article |
Language: | EN |
Published: |
Dove Medical Press
2013
|
Subjects: | |
Online Access: | https://doaj.org/article/a3c167dd3c694b13b81aa2a8ab32b0ce |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Primary treatment of diabetic macular edema
by: Tushar M Ranchod, et al.
Published: (2009) -
Contralateral eye-to-eye comparison of intravitreal ranibizumab and a sustained-release dexamethasone intravitreal implant in recalcitrant diabetic macular edema
by: Thomas BJ, et al.
Published: (2016) -
Predictors of Early Diabetic Retinopathy Regression with Ranibizumab in the RIDE and RISE Clinical Trials
by: Singer M, et al.
Published: (2020) -
Full-thickness macular hole formation following anti-VEGF injections for neovascular age-related macular degeneration
by: Kabanarou SA, et al.
Published: (2017) -
Cost-Effectiveness of Conbercept vs. Ranibizumab for Age-Related Macular Degeneration, Diabetic Macular Edema, and Pathological Myopia: Population-Based Cohort Study and Markov Model
by: Zhuang Cui, et al.
Published: (2021)